The PI3K/AKT pathway is known to play a central role in cell development and metabolism and is often stimulated in HCC patients, contributing to the invasiveness, metastasis, and aggressiveness of cancer cells [31,32]. Here, AKT1 is linked to hepatocellular carcinoma.